Cargando…

Canagliflozin Prevents Lipid Accumulation, Mitochondrial Dysfunction, and Gut Microbiota Dysbiosis in Mice With Diabetic Cardiovascular Disease

Type 2 diabetes mellitus (T2DM) is associated with cardiovascular disease (CVD) and sodium glucose cotransporter 2 inhibitors, as oral medications for T2DM treatment have shown the potential to improve vascular dysfunction. The aim of this study was to evaluate the ability of canagliflozin (Cana) to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xueliang, Wang, Zhe, Liu, Di, Jiang, Hao, Cai, Chao, Li, Guoyun, Yu, Guangli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905428/ https://www.ncbi.nlm.nih.gov/pubmed/35281938 http://dx.doi.org/10.3389/fphar.2022.839640

Ejemplares similares

Porphyran From Porphyra haitanensis Alleviates Obesity by Reducing Lipid Accumulation and Modulating gut Microbiota Homeostasis
por: Wang, Xueliang, et al.
Publicado: (2022)

Angong Niuhuang Pill ameliorates cerebral ischemia/reperfusion injury in mice partly by restoring gut microbiota dysbiosis
por: Zhang, Han, et al.
Publicado: (2022)

Stewed Rhubarb Decoction Ameliorates Adenine-Induced Chronic Renal Failure in Mice by Regulating Gut Microbiota Dysbiosis
por: Wang, Rui, et al.
Publicado: (2022)

Structural Characterization of Peptides From Huangjiu and Their Regulation of Hepatic Steatosis and Gut Microbiota Dysbiosis in Hyperlipidemia Mice
por: Shi, Ying, et al.
Publicado: (2021)

Canagliflozin for Prevention of Cardiovascular and Renal Outcomes in type2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Tian, Lei, et al.
Publicado: (2021)

Danggui-Shaoyao-San Improves Gut Microbia Dysbiosis and Hepatic Lipid Homeostasis in Fructose-Fed Rats
por: Yin, Jing, et al.
Publicado: (2021)

The Role of Gut Microbiota—Gut—Brain Axis in Perioperative Neurocognitive Dysfunction
por: Lu, Jian, et al.
Publicado: (2022)

CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome
por: Zheng, Cankun, et al.
Publicado: (2022)

Gut Microbial Dysbiosis and Cognitive Impairment in Bipolar Disorder: Current Evidence
por: Dai, Wenyu, et al.
Publicado: (2022)

Dysbiosis of the gut microbiota in disease
por: Carding, Simon, et al.
Publicado: (2015)

Atractylodin Attenuates Dextran Sulfate Sodium-Induced Colitis by Alleviating Gut Microbiota Dysbiosis and Inhibiting Inflammatory Response Through the MAPK Pathway
por: Qu, Linghang, et al.
Publicado: (2021)

Crosstalk Between Polygonatum kingianum, the miRNA, and Gut Microbiota in the Regulation of Lipid Metabolism
por: Dong, Jincai, et al.
Publicado: (2021)

Editorial: Gut Microbiota and Inflammation: Relevance in Cancer and Cardiovascular Disease
por: Parolini, Cinzia, et al.
Publicado: (2020)

Hypertension Is Associated With Intestinal Microbiota Dysbiosis and Inflammation in a Brazilian Population
por: Silveira-Nunes, Gabriela, et al.
Publicado: (2020)

Olanzapine-induced lipid disturbances: A potential mechanism through the gut microbiota-brain axis
por: Zhu, Zhenyu, et al.
Publicado: (2022)

Canagliflozin Inhibits Human Endothelial Cell Proliferation and Tube Formation
por: Behnammanesh, Ghazaleh, et al.
Publicado: (2019)

Modulation of Gut Microbiota and Metabolites by Berberine in Treating Mice With Disturbances in Glucose and Lipid Metabolism
por: Fang, Xinyi, et al.
Publicado: (2022)

Gut microbiota dysbiosis contributes to the development of hypertension
por: Li, Jing, et al.
Publicado: (2017)

The regulatory effects of second-generation antipsychotics on lipid metabolism: Potential mechanisms mediated by the gut microbiota and therapeutic implications
por: Chen, Hui, et al.
Publicado: (2023)

Ferulic Acid Ameliorates Atherosclerotic Injury by Modulating Gut Microbiota and Lipid Metabolism
por: Gu, Yuyan, et al.
Publicado: (2021)

The gut dysbiosis-cancer axis: illuminating novel insights and implications for clinical practice
por: Asseri, Amer H., et al.
Publicado: (2023)

The effect of gut microbiota dysbiosis on patients with preeclampsia
por: Zhao, Yefang, et al.
Publicado: (2023)

Human Gut Microbiota: Dysbiosis and Manipulation
por: Shen, Dongqian, et al.
Publicado: (2012)

Gut Microbiota Dysbiosis in Functional Dyspepsia
por: Tziatzios, Georgios, et al.
Publicado: (2020)

Problems with the concept of gut microbiota dysbiosis
por: Brüssow, Harald
Publicado: (2019)

Development of the gut microbiota and dysbiosis in children
por: AKAGAWA, Shohei, et al.
Publicado: (2020)

Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy
por: Huang, Yinhua, et al.
Publicado: (2021)

The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders
por: Urrutia, Pamela J., et al.
Publicado: (2014)

Canagliflozin alleviates high glucose-induced peritoneal fibrosis via HIF-1α inhibition
por: Wang, Jian, et al.
Publicado: (2023)

Far from the Eyes, Close to the Heart: Dysbiosis of Gut Microbiota and Cardiovascular Consequences
por: Serino, Matteo, et al.
Publicado: (2014)

Neonatal Streptococcus pneumoniae infection induces long-lasting dysbiosis of the gut microbiota in a mouse model
por: Li, Yuanyuan, et al.
Publicado: (2022)

Canagliflozin alters the gut, oral, and ocular surface microbiota of patients with type 2 diabetes mellitus
por: Wang, Limin, et al.
Publicado: (2023)

The Effects of Erchen Decoction on Gut Microbiota and Lipid Metabolism Disorders in Zucker Diabetic Fatty Rats
por: Zhao, Tian, et al.
Publicado: (2021)

Gut microbiota: A new therapeutic target for diabetic cardiomyopathy
por: Yuan, Suxin, et al.
Publicado: (2022)

Preventive Role of Salsalate in Diabetes Is Associated With Reducing Intestinal Inflammation Through Improvement of Gut Dysbiosis in ZDF Rats
por: Zhang, Xinrong, et al.
Publicado: (2020)

Corrigendum: The effect of gut microbiota dysbiosis on patients with preeclampsia
por: Zhao, Yefang, et al.
Publicado: (2023)

Periodontitis may induce gut microbiota dysbiosis via salivary microbiota
por: Bao, Jun, et al.
Publicado: (2022)

Dysbiosis of Gut Microbiota and Intestinal Barrier Dysfunction in Pigs with Pulmonary Inflammation Induced by Mycoplasma hyorhinis Infection
por: Zhang, Yingying, et al.
Publicado: (2022)

Gut Microbiota Dysbiosis in the Development and Progression of Gastric Cancer
por: Miao, Yingying, et al.
Publicado: (2022)

Retraction: Human gut microbiota: dysbiosis and manipulation
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mb8mgqjjcsaldkjjj5tn64gjgi